Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | TACR2 | P21452 | 2/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | TST | Q16762 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2872821 | 0.76 | ESR1 (0.41) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL104946 | 0.63 | ESR1 (0.55) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL21698806 | 0.63 | ESR1 (0.59) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL692205 | 0.62 | ESR1 (0.53) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL28797212 | 0.62 | ESR1 (0.63) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL9861541 | 0.61 | ESR1 (0.56) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL28358797 | 0.61 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL983854 | 0.61 | ESR1 (0.57) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL31745134 | 0.60 | ESR1 (0.47) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL17206940 | 0.60 | ESR1 (0.55) | ESR1ADRA2AADORA3TACR2SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022190965-A1 | BEAUTY METHOD | 株式会社 資生堂 | 2022-09-15 | — | — | WO | claimed |
| EP-1468674-B1 | Aqueous sunscreen composition containing at least an amphiphilic polymer of acrylamido 2-methyl-propane sulfonic acid and a water soluble silicone, uses thereof | OREAL (FR) | 2009-11-11 | — | — | EP | claimed |
| EP-1187598-B1 | MICROPIGMENT MIXTURE | BASF SE (DE) | 2009-10-21 | — | — | EP | claimed |
| US-11952492-B2 | Biodegradable, controlled release microcapsules | ENCAPSYS, LLC (US) | 2024-04-09 | — | — | US | disclosed |
| EP-4247537-A1 | BIODEGRADABLE, CONTROLLED RELEASE MICROCAPSULES | Encapsys, LLC (US) | 2023-09-27 | — | — | EP | disclosed |
| US-11717471-B2 | Hydrogel microcapsules | ISP INVESTMENTS LLC (US) | 2023-08-08 | — | — | US | disclosed |
| EP-4167929-A1 | METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION | BASF SE (DE) | 2023-04-26 | — | — | EP | disclosed |
| WO-2022190965-A1 | BEAUTY METHOD | 株式会社 資生堂 | 2022-09-15 | — | — | WO | disclosed |
| WO-2022109163-A1 | BIODEGRADABLE, CONTROLLED RELEASE MICROCAPSULES | ENCAPSYS, LLC (US) | 2022-05-27 | — | — | WO | disclosed |
| US-20220162444-A1 | BIODEGRADABLE, CONTROLLED RELEASE MICROCAPSULES | ENCAPSYS, LLC (US) | 2022-05-26 | — | — | US | disclosed |
| US-20220096337-A1 | COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR PERSONAL CARE APPLICATIONS | BASF SE (DE) | 2022-03-31 | — | — | US | disclosed |
| EP-2179986-A1 | Mixtures of alkylsulfosuccinates and their use | Cognis IP Management GmbH (DE) | 2010-04-28 | — | — | EP | disclosed |
| EP-2116221-A1 | Cosmetic preparation containing hydrocarbons | Cognis IP Management GmbH (DE) | 2009-11-11 | — | — | EP | disclosed |
| EP-2111847-A1 | Hydrocarbon mixtures and their use | Cognis IP Management GmbH (DE) | 2009-10-28 | — | — | EP | disclosed |
| EP-1187598-B1 | MICROPIGMENT MIXTURE | BASF SE (DE) | 2009-10-21 | — | — | EP | disclosed |
| EP-1762217-A1 | Sunscreen composition comprising PPG-3 Benzyl Ether Myristate | Beiersdorf AG (DE) | 2007-03-14 | — | — | EP | disclosed |
| EP-1541136-A1 | UV light-stable semi-solid transdermal systems comprising a photosensitive active agent and an UV-absorbing component | Schering AG (DE) | 2005-06-15 | — | — | EP | disclosed |
| US-20030165443-A1 | Composition containing a dibenzoylmethane derivative and an alpha-alkylstyrene dimer uv stabilising method | L'OREAL (FR) | 2003-09-04 | — | — | US | disclosed |
| EP-1187598-A1 | MICROPIGMENT MIXTURE | Ciba SC Holding AG (CH) | 2002-03-20 | — | — | EP | disclosed |
| WO-2000078277-A1 | MICROPIGMENT MIXTURE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2000-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11717471-B2 | Hydrogel microcapsules | MITF, DSG1, SHH | ESR1 4670/4885ADRA2A 4410/4885ADORA3 4862/4885 |
| US-20220096337-A1 | COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR PERSONAL CARE APPLICATIONS | CUTA, LIPA, PLIN5 | ESR1 4751/4885ADRA2A 3572/4885ADORA3 3981/4885 |
| US-20030165443-A1 | Composition containing a dibenzoylmethane derivative and an alpha-alkylstyrene dimer uv stabilising method | DSG1, DDT, CUTA | ESR1 4096/4885ADRA2A 2830/4885ADORA3 3014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.